MDxHealth SA
MDXH
$1.48
-$0.02-1.33%
| 06/30/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 32.33% | 50.48% | 73.48% | 142.58% | 140.75% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 32.33% | 50.48% | 73.48% | 142.58% | 140.75% |
| Cost of Revenue | 31.35% | 18.70% | 37.84% | 69.98% | 83.42% |
| Gross Profit | 32.99% | 75.40% | 101.72% | 241.07% | 206.54% |
| SG&A Expenses | 12.32% | 13.03% | 16.73% | 66.89% | 60.06% |
| Depreciation & Amortization | -49.84% | 41.81% | -- | -- | -- |
| Other Operating Expenses | 31.03% | -436.64% | -110.43% | 78.83% | 24,233.33% |
| Total Operating Expenses | 19.79% | 13.00% | 22.09% | 52.35% | 67.77% |
| Operating Income | 7.34% | 38.75% | 45.90% | 15.57% | -11.02% |
| Income Before Tax | -8.49% | 12.92% | 26.31% | -8.06% | -41.58% |
| Income Tax Expenses | -- | -99.22% | -- | -- | -- |
| Earnings from Continuing Operations | -8.49% | 13.81% | 25.60% | -8.05% | -41.58% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.49% | 13.81% | 25.60% | -8.05% | -41.58% |
| EBIT | 7.34% | 38.75% | 45.90% | 15.57% | -11.02% |
| EBITDA | 9.89% | 46.80% | 66.23% | 28.82% | -0.23% |
| EPS Basic | -1.47% | 49.66% | 52.79% | 42.62% | -6.00% |
| Normalized Basic EPS | 23.66% | 93.70% | -- | 52.34% | -- |
| EPS Diluted | -1.47% | 49.66% | 52.79% | 42.62% | -6.00% |
| Normalized Diluted EPS | 23.66% | 93.70% | -- | 52.34% | -- |
| Average Basic Shares Outstanding | 6.92% | 71.21% | 57.60% | 88.29% | 33.57% |
| Average Diluted Shares Outstanding | 6.92% | 71.21% | 57.60% | 88.29% | 33.57% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
